Esters of alkycarboxy amino acids as prodrugs of modulators of the kainate receptor
申请人:Annovis, Inc.
公开号:US20020115721A1
公开(公告)日:2002-08-22
Disclosed are prodrug compounds of a class of alkyl carboxy amino acid analogs of glutamic acid that act as specific regulators of the kainate EAA receptor cation channel. These compounds are useful for treating neurological, neuropsychological, neuropsychiatric, neurodegenerative, neuropsychopharmacological and functional disorders associated with excessive or insufficient activation of the kainate subtype of the ionotropic EAA receptors; treating cognitive disorders associated with deactivation, suboptimal activation or over-activation of the kainate receptor; alleviating pain and improving and enhancing memory, learning, and associated mental processes.
本发明涉及一类丙基羧基氨基酸类谷氨酸类似物的前药化合物,它们作为特异性调节kainate EAA受体阳离子通道的调节剂。这些化合物可用于治疗与离子型EAA受体kainate亚型过度或不足激活相关的神经、神经心理、神经精神、神经退行性、神经精神药理学和功能障碍;治疗与kainate受体去活化、亚最佳激活或过度激活相关的认知障碍;缓解疼痛并改善和增强记忆、学习和相关的心理过程。